Introducing the Scientific Value Return Network
Empowering Biotech Innovators to Fast-Track Scientific Breakthroughs.
SVRN was founded to address the disparity between the growing productivity of biomedical R&D and the diminishing efficiency of the financial and commercial infrastructure supporting biomedical innovation. We're building a community to explore:
Collaborative opportunities
Accessibility of information and resources to compile and analyze data and increase transparency in drug development research..
Alternative funding solutions beyond traditional capital
Access to capital through royalty or revenue financing can advance priority development activities without ceding leadership control.
Novel ways to maximize IP value
Expanding the reach of intellectual property using strategic licensing and partnerships can create the most potential paths to patients.
SVRN’s Research Portal showcases early-stage biopharma research with the goal of promoting transparency. We are gathering insights from founders and researchers to design the next generation of IP marketplace and help shape how early-stage biopharma research can be funded.
Current Drug Market Figures
Average cost to bring a drug to market.
Biotechs seeking funding across the globe.
Private capital deployed in 2023 to purchase drug royalties.
Clinical studies registered globally in 2024.
SVRN aims to find solutions to accelerate and protect the return of value created by the innovation ecosystem, propelling scientific progress aligned to public interest and needs.
Community
Follow our project, share ideas, and join early discussions to shape the future of biotech IP commercialization. #joinourcommunity
Book a call with usInnovator
Join our network of biotech innovators seeking visibility for their work and access to support. Apply to be listed in our beta Innovation Hub to share your experiences and challenges in drug development and commercialization. #joinsvrn
Book a call with usInvestor
Looking for opportunities to support biomedical innovation? We are constantly growing our network of investors seeking to advance drug development by connecting with others exploring alternative funding models. #investinscience
Book a call with usWith over 30 years of combined experience, our founding team is dedicated to accelerating innovation and ensuring life-changing innovations are accessible to patients around the world.
❝SVRN is composed of a core team and community passionate about offering long-term solutions to empower biomedical innovation and protect the return ecosystem that fuels future innovations for decades to come.
Max Hunt
Partner, Trinity Life Sciences
- • 12+ years experience in life science consulting
- • Work across US and global markets with 16 of top 20 biopharma companies
- • Thought leader in drug pricing and market access for innovative medicines
Hui Huang, PHD
Co-Founder, Etheros Health Data Foundation / CEO, CSD Partners
- • 20+ years experience in biopharma; former Global Vice President of Takeda Oncology
- • 30+ scientific research publications
- • Deep experience leading assets from pre-clinical through post-commercialization stages
A comprehensive FAQ section that provides quick and easy access to all the information you need to understand our product.
How are new marketplace listings vetted?
SVRN team members vet potential IP listings from potential biotechs and partnered tech transfer offices. Researchers are welcome to reach out to SVRN directly to be listed on our platform.
What is the benefit of listing on SVRN?
The SVRN marketplace allows biomedical research and development projects to gain visibility to enable connections to partners, investors, and other interested parties. Community engagement also allows for the open sharing of knowledge to guide decision-making.
Can details of my research project be anonymized?
Yes, SVRN intends to promote visibility of research projects while appreciating the importance of confidentiality on various aspects of the work. The extent of transparency of the listing is fully customizable.